Global Mycobacterium Tuberculosis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 324075
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Mycobacterium Tuberculosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Mycobacterium Tuberculosis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Mycobacterium Tuberculosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Real-time Inspection segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Mycobacterium Tuberculosis include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Mycobacterium Tuberculosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Real-time Inspection

Nucleic Acid Amplification Test

Skin Test for Tuberculosis

Other

Market segment by Application, can be divided into

Hospital

Specialist Clinic

Diagnostic Laboratory

Market segment by players, this report covers

Lupin

Macleods Pharmaceuticals

Otsuka Pharmaceutical

Johnson & Johnson

Pfizer

Novartis

Abbott

AstraZeneca

Bayer

Merck

Sanofi

Thermo Fisher Scientific

Danaher

Roche

Novartis

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Mycobacterium Tuberculosis product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Mycobacterium Tuberculosis, with revenue, gross margin and global market share of Mycobacterium Tuberculosis from 2019 to 2022.

Chapter 3, the Mycobacterium Tuberculosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Mycobacterium Tuberculosis market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Mycobacterium Tuberculosis research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Mycobacterium Tuberculosis

1.2 Classification of Mycobacterium Tuberculosis by Type

1.2.1 Overview: Global Mycobacterium Tuberculosis Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Mycobacterium Tuberculosis Revenue Market Share by Type in 2021

1.2.3 Real-time Inspection

1.2.4 Nucleic Acid Amplification Test

1.2.5 Skin Test for Tuberculosis

1.2.6 Other

1.3 Global Mycobacterium Tuberculosis Market by Application

1.3.1 Overview: Global Mycobacterium Tuberculosis Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Specialist Clinic

1.3.4 Diagnostic Laboratory

1.4 Global Mycobacterium Tuberculosis Market Size & Forecast

1.5 Global Mycobacterium Tuberculosis Market Size and Forecast by Region

1.5.1 Global Mycobacterium Tuberculosis Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Mycobacterium Tuberculosis Market Size by Region, (2017-2022)

1.5.3 North America Mycobacterium Tuberculosis Market Size and Prospect (2017-2028)

1.5.4 Europe Mycobacterium Tuberculosis Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Mycobacterium Tuberculosis Market Size and Prospect (2017-2028)

1.5.6 South America Mycobacterium Tuberculosis Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Mycobacterium Tuberculosis Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Mycobacterium Tuberculosis Market Drivers

1.6.2 Mycobacterium Tuberculosis Market Restraints

1.6.3 Mycobacterium Tuberculosis Trends Analysis

2 Company Profiles

2.1 Lupin

2.1.1 Lupin Details

2.1.2 Lupin Major Business

2.1.3 Lupin Mycobacterium Tuberculosis Product and Solutions

2.1.4 Lupin Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Lupin Recent Developments and Future Plans

2.2 Macleods Pharmaceuticals

2.2.1 Macleods Pharmaceuticals Details

2.2.2 Macleods Pharmaceuticals Major Business

2.2.3 Macleods Pharmaceuticals Mycobacterium Tuberculosis Product and Solutions

2.2.4 Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Macleods Pharmaceuticals Recent Developments and Future Plans

2.3 Otsuka Pharmaceutical

2.3.1 Otsuka Pharmaceutical Details

2.3.2 Otsuka Pharmaceutical Major Business

2.3.3 Otsuka Pharmaceutical Mycobacterium Tuberculosis Product and Solutions

2.3.4 Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Otsuka Pharmaceutical Recent Developments and Future Plans

2.4 Johnson & Johnson

2.4.1 Johnson & Johnson Details

2.4.2 Johnson & Johnson Major Business

2.4.3 Johnson & Johnson Mycobacterium Tuberculosis Product and Solutions

2.4.4 Johnson & Johnson Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Johnson & Johnson Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Mycobacterium Tuberculosis Product and Solutions

2.5.4 Pfizer Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Mycobacterium Tuberculosis Product and Solutions

2.6.4 Novartis Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Recent Developments and Future Plans

2.7 Abbott

2.7.1 Abbott Details

2.7.2 Abbott Major Business

2.7.3 Abbott Mycobacterium Tuberculosis Product and Solutions

2.7.4 Abbott Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Abbott Recent Developments and Future Plans

2.8 AstraZeneca

2.8.1 AstraZeneca Details

2.8.2 AstraZeneca Major Business

2.8.3 AstraZeneca Mycobacterium Tuberculosis Product and Solutions

2.8.4 AstraZeneca Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 AstraZeneca Recent Developments and Future Plans

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Mycobacterium Tuberculosis Product and Solutions

2.9.4 Bayer Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bayer Recent Developments and Future Plans

2.10 Merck

2.10.1 Merck Details

2.10.2 Merck Major Business

2.10.3 Merck Mycobacterium Tuberculosis Product and Solutions

2.10.4 Merck Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Merck Recent Developments and Future Plans

2.11 Sanofi

2.11.1 Sanofi Details

2.11.2 Sanofi Major Business

2.11.3 Sanofi Mycobacterium Tuberculosis Product and Solutions

2.11.4 Sanofi Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Sanofi Recent Developments and Future Plans

2.12 Thermo Fisher Scientific

2.12.1 Thermo Fisher Scientific Details

2.12.2 Thermo Fisher Scientific Major Business

2.12.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Product and Solutions

2.12.4 Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.13 Danaher

2.13.1 Danaher Details

2.13.2 Danaher Major Business

2.13.3 Danaher Mycobacterium Tuberculosis Product and Solutions

2.13.4 Danaher Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Danaher Recent Developments and Future Plans

2.14 Roche

2.14.1 Roche Details

2.14.2 Roche Major Business

2.14.3 Roche Mycobacterium Tuberculosis Product and Solutions

2.14.4 Roche Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Roche Recent Developments and Future Plans

2.15 Novartis

2.15.1 Novartis Details

2.15.2 Novartis Major Business

2.15.3 Novartis Mycobacterium Tuberculosis Product and Solutions

2.15.4 Novartis Mycobacterium Tuberculosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Mycobacterium Tuberculosis Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Mycobacterium Tuberculosis Players Market Share in 2021

3.2.2 Top 10 Mycobacterium Tuberculosis Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Mycobacterium Tuberculosis Players Head Office, Products and Services Provided

3.4 Mycobacterium Tuberculosis Mergers & Acquisitions

3.5 Mycobacterium Tuberculosis New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Mycobacterium Tuberculosis Revenue and Market Share by Type (2017-2022)

4.2 Global Mycobacterium Tuberculosis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Mycobacterium Tuberculosis Revenue Market Share by Application (2017-2022)

5.2 Global Mycobacterium Tuberculosis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Mycobacterium Tuberculosis Revenue by Type (2017-2028)

6.2 North America Mycobacterium Tuberculosis Revenue by Application (2017-2028)

6.3 North America Mycobacterium Tuberculosis Market Size by Country

6.3.1 North America Mycobacterium Tuberculosis Revenue by Country (2017-2028)

6.3.2 United States Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

6.3.3 Canada Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

6.3.4 Mexico Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Mycobacterium Tuberculosis Revenue by Type (2017-2028)

7.2 Europe Mycobacterium Tuberculosis Revenue by Application (2017-2028)

7.3 Europe Mycobacterium Tuberculosis Market Size by Country

7.3.1 Europe Mycobacterium Tuberculosis Revenue by Country (2017-2028)

7.3.2 Germany Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

7.3.3 France Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

7.3.5 Russia Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

7.3.6 Italy Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Mycobacterium Tuberculosis Revenue by Type (2017-2028)

8.2 Asia-Pacific Mycobacterium Tuberculosis Revenue by Application (2017-2028)

8.3 Asia-Pacific Mycobacterium Tuberculosis Market Size by Region

8.3.1 Asia-Pacific Mycobacterium Tuberculosis Revenue by Region (2017-2028)

8.3.2 China Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8.3.3 Japan Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8.3.4 South Korea Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8.3.5 India Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

8.3.7 Australia Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Mycobacterium Tuberculosis Revenue by Type (2017-2028)

9.2 South America Mycobacterium Tuberculosis Revenue by Application (2017-2028)

9.3 South America Mycobacterium Tuberculosis Market Size by Country

9.3.1 South America Mycobacterium Tuberculosis Revenue by Country (2017-2028)

9.3.2 Brazil Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

9.3.3 Argentina Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Mycobacterium Tuberculosis Revenue by Type (2017-2028)

10.2 Middle East & Africa Mycobacterium Tuberculosis Revenue by Application (2017-2028)

10.3 Middle East & Africa Mycobacterium Tuberculosis Market Size by Country

10.3.1 Middle East & Africa Mycobacterium Tuberculosis Revenue by Country (2017-2028)

10.3.2 Turkey Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

10.3.4 UAE Mycobacterium Tuberculosis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Mycobacterium Tuberculosis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Mycobacterium Tuberculosis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Mycobacterium Tuberculosis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Mycobacterium Tuberculosis Revenue (USD Million) by Region (2017-2022)

Table 5. Global Mycobacterium Tuberculosis Revenue Market Share by Region (2023-2028)

Table 6. Lupin Corporate Information, Head Office, and Major Competitors

Table 7. Lupin Major Business

Table 8. Lupin Mycobacterium Tuberculosis Product and Solutions

Table 9. Lupin Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Macleods Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 11. Macleods Pharmaceuticals Major Business

Table 12. Macleods Pharmaceuticals Mycobacterium Tuberculosis Product and Solutions

Table 13. Macleods Pharmaceuticals Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Otsuka Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 15. Otsuka Pharmaceutical Major Business

Table 16. Otsuka Pharmaceutical Mycobacterium Tuberculosis Product and Solutions

Table 17. Otsuka Pharmaceutical Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 19. Johnson & Johnson Major Business

Table 20. Johnson & Johnson Mycobacterium Tuberculosis Product and Solutions

Table 21. Johnson & Johnson Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Mycobacterium Tuberculosis Product and Solutions

Table 25. Pfizer Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Mycobacterium Tuberculosis Product and Solutions

Table 29. Novartis Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Abbott Corporate Information, Head Office, and Major Competitors

Table 31. Abbott Major Business

Table 32. Abbott Mycobacterium Tuberculosis Product and Solutions

Table 33. Abbott Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 35. AstraZeneca Major Business

Table 36. AstraZeneca Mycobacterium Tuberculosis Product and Solutions

Table 37. AstraZeneca Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bayer Corporate Information, Head Office, and Major Competitors

Table 39. Bayer Major Business

Table 40. Bayer Mycobacterium Tuberculosis Product and Solutions

Table 41. Bayer Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Merck Corporate Information, Head Office, and Major Competitors

Table 43. Merck Major Business

Table 44. Merck Mycobacterium Tuberculosis Product and Solutions

Table 45. Merck Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Sanofi Corporate Information, Head Office, and Major Competitors

Table 47. Sanofi Major Business

Table 48. Sanofi Mycobacterium Tuberculosis Product and Solutions

Table 49. Sanofi Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 51. Thermo Fisher Scientific Major Business

Table 52. Thermo Fisher Scientific Mycobacterium Tuberculosis Product and Solutions

Table 53. Thermo Fisher Scientific Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Danaher Corporate Information, Head Office, and Major Competitors

Table 55. Danaher Major Business

Table 56. Danaher Mycobacterium Tuberculosis Product and Solutions

Table 57. Danaher Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Roche Corporate Information, Head Office, and Major Competitors

Table 59. Roche Major Business

Table 60. Roche Mycobacterium Tuberculosis Product and Solutions

Table 61. Roche Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Novartis Corporate Information, Head Office, and Major Competitors

Table 63. Novartis Major Business

Table 64. Novartis Mycobacterium Tuberculosis Product and Solutions

Table 65. Novartis Mycobacterium Tuberculosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Mycobacterium Tuberculosis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Mycobacterium Tuberculosis Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Mycobacterium Tuberculosis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Mycobacterium Tuberculosis Players Head Office, Products and Services Provided

Table 70. Mycobacterium Tuberculosis Mergers & Acquisitions in the Past Five Years

Table 71. Mycobacterium Tuberculosis New Entrants and Expansion Plans

Table 72. Global Mycobacterium Tuberculosis Revenue (USD Million) by Type (2017-2022)

Table 73. Global Mycobacterium Tuberculosis Revenue Share by Type (2017-2022)

Table 74. Global Mycobacterium Tuberculosis Revenue Forecast by Type (2023-2028)

Table 75. Global Mycobacterium Tuberculosis Revenue by Application (2017-2022)

Table 76. Global Mycobacterium Tuberculosis Revenue Forecast by Application (2023-2028)

Table 77. North America Mycobacterium Tuberculosis Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Mycobacterium Tuberculosis Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Mycobacterium Tuberculosis Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Mycobacterium Tuberculosis Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Mycobacterium Tuberculosis Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Mycobacterium Tuberculosis Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Mycobacterium Tuberculosis Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Mycobacterium Tuberculosis Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Mycobacterium Tuberculosis Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Mycobacterium Tuberculosis Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Mycobacterium Tuberculosis Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Mycobacterium Tuberculosis Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Mycobacterium Tuberculosis Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Mycobacterium Tuberculosis Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Mycobacterium Tuberculosis Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Mycobacterium Tuberculosis Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Mycobacterium Tuberculosis Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Mycobacterium Tuberculosis Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Mycobacterium Tuberculosis Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Mycobacterium Tuberculosis Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Mycobacterium Tuberculosis Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Mycobacterium Tuberculosis Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Mycobacterium Tuberculosis Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Mycobacterium Tuberculosis Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Mycobacterium Tuberculosis Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Mycobacterium Tuberculosis Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Mycobacterium Tuberculosis Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Mycobacterium Tuberculosis Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Mycobacterium Tuberculosis Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Mycobacterium Tuberculosis Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Mycobacterium Tuberculosis Picture

Figure 2. Global Mycobacterium Tuberculosis Revenue Market Share by Type in 2021

Figure 3. Real-time Inspection

Figure 4. Nucleic Acid Amplification Test

Figure 5. Skin Test for Tuberculosis

Figure 6. Other

Figure 7. Mycobacterium Tuberculosis Revenue Market Share by Application in 2021

Figure 8. Hospital Picture

Figure 9. Specialist Clinic Picture

Figure 10. Diagnostic Laboratory Picture

Figure 11. Global Mycobacterium Tuberculosis Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Mycobacterium Tuberculosis Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Mycobacterium Tuberculosis Revenue Market Share by Region (2017-2028)

Figure 14. Global Mycobacterium Tuberculosis Revenue Market Share by Region in 2021

Figure 15. North America Mycobacterium Tuberculosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Mycobacterium Tuberculosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Mycobacterium Tuberculosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Mycobacterium Tuberculosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Mycobacterium Tuberculosis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Mycobacterium Tuberculosis Market Drivers

Figure 21. Mycobacterium Tuberculosis Market Restraints

Figure 22. Mycobacterium Tuberculosis Market Trends

Figure 23. Lupin Recent Developments and Future Plans

Figure 24. Macleods Pharmaceuticals Recent Developments and Future Plans

Figure 25. Otsuka Pharmaceutical Recent Developments and Future Plans

Figure 26. Johnson & Johnson Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. Novartis Recent Developments and Future Plans

Figure 29. Abbott Recent Developments and Future Plans

Figure 30. AstraZeneca Recent Developments and Future Plans

Figure 31. Bayer Recent Developments and Future Plans

Figure 32. Merck Recent Developments and Future Plans

Figure 33. Sanofi Recent Developments and Future Plans

Figure 34. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 35. Danaher Recent Developments and Future Plans

Figure 36. Roche Recent Developments and Future Plans

Figure 37. Novartis Recent Developments and Future Plans

Figure 38. Global Mycobacterium Tuberculosis Revenue Share by Players in 2021

Figure 39. Mycobacterium Tuberculosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Mycobacterium Tuberculosis Revenue Market Share in 2021

Figure 41. Global Top 10 Players Mycobacterium Tuberculosis Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Mycobacterium Tuberculosis Revenue Share by Type in 2021

Figure 44. Global Mycobacterium Tuberculosis Market Share Forecast by Type (2023-2028)

Figure 45. Global Mycobacterium Tuberculosis Revenue Share by Application in 2021

Figure 46. Global Mycobacterium Tuberculosis Market Share Forecast by Application (2023-2028)

Figure 47. North America Mycobacterium Tuberculosis Sales Market Share by Type (2017-2028)

Figure 48. North America Mycobacterium Tuberculosis Sales Market Share by Application (2017-2028)

Figure 49. North America Mycobacterium Tuberculosis Revenue Market Share by Country (2017-2028)

Figure 50. United States Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Mycobacterium Tuberculosis Sales Market Share by Type (2017-2028)

Figure 54. Europe Mycobacterium Tuberculosis Sales Market Share by Application (2017-2028)

Figure 55. Europe Mycobacterium Tuberculosis Revenue Market Share by Country (2017-2028)

Figure 56. Germany Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Mycobacterium Tuberculosis Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Mycobacterium Tuberculosis Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Mycobacterium Tuberculosis Revenue Market Share by Region (2017-2028)

Figure 64. China Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Mycobacterium Tuberculosis Sales Market Share by Type (2017-2028)

Figure 71. South America Mycobacterium Tuberculosis Sales Market Share by Application (2017-2028)

Figure 72. South America Mycobacterium Tuberculosis Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Mycobacterium Tuberculosis Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Mycobacterium Tuberculosis Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Mycobacterium Tuberculosis Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Mycobacterium Tuberculosis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz